Reserve "Low T" Treatment for Symptomatic Men With Repeatedly Low Levels

May 2014

Please see the March 2015 FDA notice concerning the possible increased risk of heart attack/stroke associated with testosterone use.

The debate about treating "low T" in older men will heat up...due to controversy over testosterone's cardiovascular risk.

A recent JAMA study has FDA investigating a possible link between testosterone therapy and MIs and strokes.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Cardiology Avoid the New Anticoagulants in Patients With Mechanical Valves
Testosterone Reserve "Low T" Treatment for Symptomatic Men With Repeatedly Low Levels
Alzheimer's Disease Re-Evaluate Whether Namenda Is Helping Your Alzheimer's Patients
Cardiology Use a High-Dose Statin for Most Post-ACS Patients
Respiratory & Allergy Teach Patients How to Use Spacers with Metered Dose Inhalers
Neurology & Pain Stick With Traditional Opioid Formulations for Most Patients
Dermatology Recommend OTC Butenafine or Terbinafine First for Tinea Infections
Diabetes Be Aware of Meds That Increase Diabetes Risk
Geriatrics Look for Alternatives to High-Risk Meds in Elderly Patients
Women's Health Use COMBINED Hormonal Contraceptives for Most Women with PCOS
Supplements Advise Most Patients They Don't Need a Multivitamin
Cardiology Ensure MI Patients Get the Right Discharge Meds
OTC Products Be Aware that Mucinex Allergy does NOT Contain Guaifenesin